Pain Therapeutics (PTIE) COO Nadav Friedmann sells 15,000 Shares

COO of Pain Therapeutics (PTIE, Financial) Nadav Friedmann sells 15,000 shares of PTIE on 04/01/2010 at an average price of $6.17 a share.

Pain Therapeutics has a market cap of $262.2 million; its shares were traded at around $6.2 with and P/S ratio of 12.8.

PTIE is in the portfolios of Daniel Loeb of Third Point, LLC, Richard Perry of Perry Capital, Jim Simons of Renaissance Technologies LLC.

CEO Recent Trades:

  • Sell:: CEO and Chairman of the Board, 10% Owner Remi Barbier sold 12,000 shares of PTIE stock on 04/01/2010 at the average price of 6.16, the price of the stock has increased by 0.65% since.

  • Sell:: CEO and Chair of Board, 10% Owner Remi Barbier sold 5,443 shares of PTIE stock on 03/03/2010 at the average price of 6.13, the price of the stock has increased by 1.14% since.

  • Sell:: CEO and Chair of the Board, 10% Owner Remi Barbier sold 44,557 shares of PTIE stock on 03/02/2010 at the average price of 6.07, the price of the stock has increased by 2.14% since.

  • Sell:: CEO, President, Chairman of Bd, 10% Owner Remi Barbier sold 50,000 shares of PTIE stock on 02/02/2010 at the average price of 5.32, the price of the stock has increased by 16.54% since.

  • Sell:: CEO, Chairman of Board, 10% Owner Remi Barbier sold 50,000 shares of PTIE stock on 01/06/2010 at the average price of 5.39, the price of the stock has increased by 15.03% since.



Directors and Officers Recent Trades:

  • Sell:: Chief Scientific Officer Grant Schoenhard sold 35,000 shares of PTIE stock on 03/16/2010 at the average price of 6.13, the price of the stock has increased by 1.14% since.

  • Sell:: Director Donnell Michael J O sold 25,000 shares of PTIE stock on 03/11/2010 at the average price of 6.14, the price of the stock has increased by 0.98% since.

  • Sell:: COO Nadav Friedmann sold 15,000 shares of PTIE stock on 11/16/2009 at the average price of 5, the price of the stock has increased by 24% since.